# FDA Inspection 1210671 - Ardelyx, Inc. - July 24, 2023

Source: https://www.globalkeysolutions.net/records/fda_inspections/ardelyx-inc/7a235bd5-1b51-4cfa-8fc7-3cb7d8ccc158
Source feed: FDA_Inspections

> FDA Inspection 1210671 for Ardelyx, Inc. on July 24, 2023. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1210671
- Company Name: Ardelyx, Inc.
- Inspection Date: 2023-07-24
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1083980 - 2019-03-12](https://www.globalkeysolutions.net/records/fda_inspections/ardelyx-inc/0fe3d5fe-0391-46a3-988c-db033c7bf753)

Company: https://www.globalkeysolutions.net/companies/ardelyx-inc/ca34caa9-3440-4e27-a0d0-177a42cc469e

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c